Document Detail


Toxic epidermal necrolysis and Stevens-Johnson syndrome: A review*
MedLine Citation:
PMID:  21358399     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVES:: The aims of this review are to summarize the definitions, causes, and clinical course as well as the current understanding of the genetic background, mechanism of disease, and therapy of toxic epidermal necrolysis and Stevens-Johnson syndrome. DATA SOURCES:: PubMed was searched using the terms toxic epidermal necrolysis, Stevens-Johnson syndrome, drug toxicity, drug interaction, and skin diseases. DATA SYNTHESIS:: Toxic epidermal necrolysis and Stevens-Johnson syndrome are acute inflammatory skin reactions. The onset is usually triggered by infections of the upper respiratory tract or by preceding medication, among which nonsteroidal anti-inflammatory agents, antibiotics, and anticonvulsants are the most common triggers. Initially the diseases present with unspecific symptoms, followed by more or less extensive blistering and shedding of the skin. Complete death of the epidermis leads to sloughing similar to that seen in large burns. Toxic epidermal necrolysis is the most severe form of drug-induced skin reaction and includes denudation of >30% of total body surface area. Stevens-Johnson syndrome affects <10%, whereas involvement of 10%-30% of body surface area is called Stevens-Johnson syndrome/toxic epidermal necrolysis overlap. Besides the skin, mucous membranes such as oral, genital, anal, nasal, and conjunctival mucosa are frequently involved in toxic epidermal necrolysis and Stevens-Johnson syndrome. Toxic epidermal necrolysis is associated with a significant mortality of 30%-50% and long-term sequelae. Treatment includes early admission to a burn unit, where treatment with precise fluid, electrolyte, protein, and energy supplementation, moderate mechanical ventilation, and expert wound care can be provided. Specific treatment with immunosuppressive drugs or immunoglobulins did not show an improved outcome in most studies and remains controversial. The mechanism of disease is not completely understood, but immunologic mechanisms, cytotoxic reactions, and delayed hypersensitivity seem to be involved. CONCLUSION:: Profound knowledge of exfoliative skin diseases is needed to improve therapy and outcome of these life-threatening illnesses.
Authors:
Roland Gerull; Mathias Nelle; Thomas Schaible
Related Documents :
6292369 - Persisting nutritional neuropathy amongst former war prisoners.
21455429 - A hidden history of heartburn: the milk-alkali syndrome.
2168779 - Benign hereditary cerebellar ataxia with extensive thermoanalgesia.
20816579 - Hereditary genodermatoses with cancer predisposition.
21440909 - Skin involvement in susac's syndrome.
22573359 - Adaptations for marine habitat and the effect of triassic and jurassic predator pressur...
2655139 - Ocular choristomas.
10160419 - Recent advances in hereditary disease and neuro-ophthalmology.
8179499 - Reverse shapiro's syndrome. a case of agenesis of corpus callosum associated with perio...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-2-24
Journal Detail:
Title:  Critical care medicine     Volume:  -     ISSN:  1530-0293     ISO Abbreviation:  -     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-3-1     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0355501     Medline TA:  Crit Care Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
From the Department of Neonatology (MN, RG), Inselspital Bern, Bern, Switzerland; and Department of Neonatology/Pediatric Intensive Care (TS), University Hospital Mannheim, Mannheim, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Neurologic complications and outcomes of infective endocarditis in critically ill patients: the ENDO...
Next Document:  Procalcitonin for reduced antibiotic exposure in the critical care setting: A systematic review and ...